Allarity TherapeuticsALLR
13F holders, Q1 2026 (March 31)14holders −2
3new positions
6sold out
1famous investor
$1.09avg. 13F price*
At the end of Q1 2026, 14 institutions reported holding Allarity Therapeutics Inc. (ALLR) in their 13F filings, down 2 from Q4 2025. 3 opened new positions and 6 sold out. The largest holders were Renaissance Technologies ($249K), Geode Capital Management, LLC ($208K) and Vanguard Capital Management LLC ($187K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Allarity Therapeutics Inc.
- CUSIP
- 016744500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $8K |
| Exits | 6 | $403K |
All 13F filers, Q4 2025 → Q1 2026: 60,682 shares bought and 402,178 shares sold, net −341,496 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Renaissance Technologies | 0.00% | Reduce -7.9% | 228,084 | $249K |
| Geode Capital Management, LLC | 0.00% | Add +21.6% | 190,393 | $208K |
| Vanguard Capital Management LLC | 0.00% | — | 171,795 | $187K |
| State Street Corp. | 0.00% | No change | 137,600 | $150K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 74,913 | $82K |
| Northern Trust Corp. | 0.00% | Add +66.2% | 48,103 | $52K |
| XTX Topco Ltd | 0.00% | Reduce -13.9% | 28,967 | $32K |
| Two Sigma Investments, LP | 0.00% | No change | 27,492 | $30K |
| UBS Group AG | 0.00% | Reduce -12.7% | 23,158 | $25K |
| Two Sigma Securities, LLC | 0.00% | Reduce -9.3% | 12,334 | $13K |
| Citigroup Inc. | 0.00% | New | 7,766 | $8K |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| Jones Financial Companies LLLP | 0.00% | New | 1 | $1 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is ALLR's weight in each manager's 13F, not the share of Allarity Therapeutics Inc. the manager owns.